HKUMed research with Hong Kong Genome Institute uncovers new glioblastoma treatment targets
Glioblastoma, the most common and aggressive primary brain cancer in adults, has yielded thousands of previously hidden genetic clues in a study that could reshape the search for future immunotherapies. Researchers from...
Read moreDetails

